Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease

Clinical Immunology

Volumn 118, Issue 2-3, 2006, Pages 233-242

  Chistiakov, Dimitry A ^a   Savost'anov, Kirill V ^b,c   Turakulov, Rustam I ^d   Efremov, Ilya A ^b   Demurov, Lev M ^c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^c N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Association; CTLA 4; Graves' disease; LEF1; MEF2; Promoter polymorphisms

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOID ENHANCER FACTOR 1; MYOCYTE ENHANCER FACTOR 2;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE ACTIVATION; GENE EXPRESSION; GENETIC ANALYSIS; GRAVES DISEASE; HAPLOTYPE; HELA CELL; HOMOZYGOSITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; GENOTYPE; GRAVES DISEASE; HELA CELLS; HUMANS; JURKAT CELLS; LYMPHOID ENHANCER-BINDING FACTOR 1; MADS DOMAIN PROTEINS; MYOGENIC REGULATORY FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 32144456238     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.09.017     Document Type: Article

References (48)

1. J.L. Riley, and C.H. June The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation Blood 105 2005 13 21
2. O.P. Kristiansen, Z.M. Larsen, and F. Pociot CTLA-4 in autoimmune diseases-A general susceptibility gene to autoimmunity? Genes Immun. 1 2000 170 184
3. E.C. Walsh, S. Guschwan-McMahon, M.J. Daly, D.A. Hafler, and J.D. Rioux Genetic analysis of multiple sclerosis J. Autoimmun. 21 2004 111 116
4. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, A.N. Smith, G. Di Genova, M.H. Herr, I. Dahlman, F. Payne, D. Smyth, C. Lowe, R.C. Twells, S. Howlett, B. Healy, S. Nutland, H.E. Rance, V. Everett, L.J. Smink, A.C. Lam, H.J. Cordell, N.M. Walker, C. Bordin, J. Hulme, C. Motzo, F. Cucca, J.F. Hess, M.L. Metzker, J. Rogers, S. Gregory, A. Allahabadia, R. Nithiyananthan, E. Tuomilehto-Wolf, J. Tuomilehto, P. Bingley, K.M. Gillespie, D.E. Undlien, K.S. Ronningen, C. Guja, C. Ionescu-Tirgoviste, D.A. Savage, A.P. Maxwell, D.J. Carson, C.C. Patterson, J.A. Franklyn, D.G. Clayton, L.B. Peterson, L.S. Wicker, J.A. Todd, and S.C. Gough Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 2003 506 511
5. B. Vaidya, and S. Pearce The emerging role of the CTLA-4 gene in autoimmune endocrinopathies Eur. J. Endocrinol. 150 2004 619 626
6. Y.H. Lee, J.B. Harley, and S.K. Nath CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis Hum. Genet. 116 2005 361 367
7. H. Donner, H. Rau, P.G. Walfish, J. Braun, T. Siegmund, R. Finke, J. Herwig, K.H. Usadel, and K. Badenhoop CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus J. Clin. Endocrinol. Metab. 82 1997 143 146
8. T. Yanagawa, M. Taniyama, S. Enomoto, K. Gomi, H. Maruyama, Y. Ban, and T. Saruta CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese Thyroid 7 1997 843 846
9. J.M. Heward, A. Allahabadia, M. Armitage, A. Hattersley, P.M. Dodson, K. Macleod, J. Carr-Smith, J. Daykin, A. Daly, M.C. Sheppard, R.L. Holder, A.H. Barnett, J.A. Franklyn, and S.C. Gough The development of Graves' disease and the CTLA-4 gene on chromosome 2q33 J. Clin. Endocrinol. Metab. 84 1999 2398 2401
10. B. Vaidya, H. Imrie, P. Perros, E.T. Young, W.F. Kelly, D. Carr, D.M. Large, A.D. Toft, M.I. McCarthy, P. Kendall-Taylor, and S.H. Pearce The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus Hum. Mol. Genet. 8 1999 1195 1199
11. D.A. Chistyakov, K.V. Savost'anov, R.I. Turakulov, N.A. Petunina, L.V. Trukhina, A.V. Kudinova, M.I. Balabolkin, and V.V. Nosikov Complex association analysis of Graves disease using a set of polymorphic markers Mol. Genet. Metab. 70 2000 214 218
12. T. Kouki, C.A. Gardine, T. Yanagawa, and L.J. Degroot Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease J. Endocrinol. Invest. 25 2002 208 213
13. Y. Ban, E.S. Concepcion, R. Villanueva, D.A. Greenberg, T.F. Davies, and Y. Tomer Analysis of immune regulatory genes in familial and sporadic Graves' disease J. Clin. Endocrinol. Metab. 89 2004 4562 4568
14. T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman, and L.J. DeGroot CTLA4 gene polymorphism associated with Graves' disease in a Caucasian population J. Clin. Endocrinol. Metab. 80 1995 41 45
15. K. Kotsa, P.F. Watson, and A.P. Weetman A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism Clin. Endocrinol. 46 1997 551 554
16. H. Hadj Kacem, M. Bellassoued, N. Bougacha-Elleuch, M. Abid, and H. Ayadi CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease Clin. Immunol. 101 2001 361 365
17. D.A. Chistiakov, and R.I. Turakulov CTLA-4 and its role in autoimmune thyroid disease J. Mol. Endocrinol. 31 2003 21 36
18. J. Braun, H. Donner, T. Siegmund, P.G. Walfish, K.H. Usadel, and K. Badenhoop CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis Tissue Antigens 51 1998 563 566
19. Y.J. Park, H.K. Chung, D.J. Park, W.B. Kim, S.W. Kim, J.J. Koh, and B.Y. Cho Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans Thyroid 10 2000 453 459
20. J.M. Heward, A. Allahabadia, J. Carr-Smith, J. Daykin, C.S. Cockram, C. Gordon, A.H. Barnett, J.A. Franklyn, and S.C. Gough No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies Clin. Endocrinol. 49 1998 331 334
21. B. Vaidya, E.J. Oakes, H. Imrie, A.J. Dickinson, P. Perros, P. Kendall-Taylor, and S.H. Pearce CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism Clin. Endocrinol. 58 2003 732 735
22. G.C. Johnson, L. Esposito, B.J. Barratt, A.N. Smith, J. Heward, G. Di Genova, H. Ueda, H.J. Cordell, I.A. Eaves, F. Dudbridge, R.C. Twells, F. Payne, W. Hughes, S. Nutland, H. Stevens, P. Carr, E. Tuomilehto-Wolf, J. Tuomilehto, S.C. Gough, and D.G. Clayton Haplotype tagging for the identification of common disease genes Nat Genet. 29 2003 233 237
23. V. Ling, P.W. Wu, H.F. Finnerty, A.H. Sharpe, G.S. Gray, and M. Collins Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders Genomics 60 1999 341 355
24. A. Ligers, N. Teleshova, T. Masterman, W.X. Huang, and J. Hillert CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun. 2 2001 145 152
25. X.B. Wang, X. Zhao, R. Giscombe, and A.K. Lefvert A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein Genes Immun. 3 2002 233 234
26. S.M. Anjos, M.C. Tessier, and C. Polychronakos Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block J. Clin. Endocrinol. Metab. 89 2004 6257 6265
27. S.M. Anjos, W. Shao, L. Marchald, and C. Polychronakos allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a reevaluation of the 3′ +6230G>A polymorphism Genes Immun. 6 2005 305 311
28. D.A. Chistiakov, K.V. Savost'anov, and R.I. Turakulov Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study Mol. Genet. Metab. 83 2004 264 270
29. B. Torres, F. Aguilar, E. Franco, E. Sanchez, J. Sanchez-Roman, J.J. Alonso, A. Nunez-Roldan, J. Martin, and M.F. Gonzalez-Escribano Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus Arthritis Rheum. 50 2004 2211 2215
30. K. Deichmann, A. Heinzmann, E. Bruggenolte, J. Forster, and J. Kuehr An Mse I RFLP in the human CTLA4 promoter Biochem. Biophys. Res. Commun. 225 1996 817 818
31. L.L. Hudson, K. Rocca, Y.W. Song, and J.P. Pandey CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region Hum. Genet. 111 2002 452 455
32. W.W. Lorenz, R.O. McCann, M. Longiaru, and M.J. Cormier Isolation and expression of a cDNA encoding Renilla reniformis luciferase Proc. Natl. Acad. Sci. U. S. A. 88 1991 4438 4442
33. L. Kruglyak, M.L. Daly, M.P. Reeve-Daly, and E.S. Lander Parametric and nonparametric linkage analysis: a unified multipoint approach Am. J. Hum. Genet. 58 1996 1347 1363
34. K. Ding, K. Zhou, F. He, and Y. Shen LDA-A java-based linkage disequilibrium analyzer Bioinformatics 19 2003 2147 2148
35. T. Kouki, Y. Sawai, C.A. Gardine, M.E. Fisfalen, M.L. Alegre, and L.J. DeGroot CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease J. Immunol. 165 2000 6606 6611
36. M. Maurer, S. Loserth, A. Kolb-Maurer, A. Ponath, S. Wiese, N. Kruse, and P. Rieckmann A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 + 49) alters T-cell activation Immunogenetics 54 2002 1 8
37. S. Anjos, A. Nguyen, H. Ounissi-Benkalha, M.C. Tessier, and C. Polychronakos A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele J. Biol. Chem. 277 2002 46478 46486
38. T.A. McKinsey, C.L. Zhang, and E.N. Olson MEF2: a calcium-dependent regulator of cell division, differentiation and death Trends Biochem. Sci. 27 2002 40 47
39. B.J. Swanson, H.-M. Jack, and G.E. Lyons Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes Mol. Immunol. 35 1998 445 458
40. D. Yang, M. Roggendorf, and M. Lum Molecular characterization of CD28 and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) of woodchuck (Marmota monax) Tissue Antigens 62 2003 225 232
41. Y. Ban, E.S. Concepcion, R. Villanueva, D.A. Greenberg, T.F. Davies, and Y. Tomer Analysis of immune regulatory genes in familial and sporadic Graves' disease J. Clin. Endocrinol. Metab. 89 2004 4562 4568
42. K. Furugaki, S. Shirasawa, N. Ishikawa, K. Ito, K. Ito, S. Kubota, K. Kuma, H. Tamai, T. Akamizu, H. Hiratani, M. Tanaka, and T. Sasazuki Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese J. Hum. Genet. 49 2004 166 168
43. M.J. Rieder, S.L. Taylor, A.G. Clark, and D.A. Nickerson Sequence variation in the human angiotensin converting enzyme Nat. Genet. 22 1999 59 62
44. D.A. Nickerson, S.L. Taylor, S.M. Fullerton, K.M. Weiss, A.G. Clark, J.H. Stengard, V. Salomaa, E. Boerwinkle, and C.F. Sing Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene Genome Res. 10 2000 1532 1545
45. L. Levin, and Y. Tomer The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility Autoimmun. Rev. 2 2003 377 386
46. M. Oosterwegel, M. van de Wetering, and H. Clevers HMG box proteins in early T-cell differentiation Thymus 22 1993 67 81
47. K. Hovanes, T.W., and M.L. Waterman The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing Nucleic Acids Res. 28 2000 1994 2003
48. D. Perkins, Z. Wang, C. Donovan, H. He, D. Mark, G. Guan, Y. Wang, T. Walunas, J. Bluestone, J. Listman, and P.W. Finn Regulation of CTLA-4 expression during T cell activation J. Immunol. 156 1996 4154 4159